| Name | Title | Contact Details |
|---|
Futrix is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
MPOWERHealth is dedicated to empowering better healthcare through innovative solutions for specialty physicians, hospitals and payors. Its services include an integrated physician network that supports collaboration between neuromusculoskeletal physicians to promote quality improvements; best-in-class neuromonitoring services for physicians, hospitals, health systems and medical facilities; and bundled solutions for payors that create direct access to the highest level of conservative spine care at a set cost. Based in Addison, Texas, MPOWERHealth serves more than 400 physicians, 55,000-plus patients and over 300 facilities in 24 states.
Granite Microsystems is Committed to Quality and Conformance. As part of our commitment to safety and durability, Granite Microsystems' solutions conform to standard UL and CUL safety requirements. Testing is performed to ensure that appropriate products
Carepartners Health Services is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.